CV Sciences Acquires Extract Labs

CV Sciences, Inc. entered into a definitive agreement to acquire Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products, for $400,000 in cash plus $1,000,000 in CV Sciences shares at closing. Additional contingent consideration of up to $600,000 in CV Sciences shares may be earned based on Extract Labs revenue targets post-closing, which is expected in Q1 2025.